Characteristics of Cancer Stem Cells (CSCs)

Similar documents
Lecture 1: Carcinogenesis

Development of Carcinoma Pathways

micrornas!as! Biomarkers! Landscape!

number Done by Corrected by Doctor Maha Shomaf

PATHOBIOLOGY OF NEOPLASIA

microrna Therapeutics Heading Towards the Clinic

Biochemistry of Carcinogenesis. Lecture # 35 Alexander N. Koval

Lecture 1: Carcinogenesis

TARGETED THERAPY FOR CHILDHOOD CANCERS

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

Alan G. Casson FRCSC Professor of Surgery & VP Integrated Health Services University of Saskatchewan & Saskatoon Health Region

TUMOR INITIATING CELLS: THE STEM CELL THEORY OF CANCER

Should novel molecular therapies replace old knowledge of clinical tumor biology?

609G: Concepts of Cancer Genetics and Treatments (3 credits)

Overview of Cancer. Mylene Freires Advanced Nurse Practitioner, Haematology

BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

Human Lung Cancer Pathology and Cellular Biology Mouse Lung Tumor Workshop

Founded in 2016 to develop life-changing therapies against debilitating aggressive cancers that have limited treatment options

GENReports: Market & Tech Analysis

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Neoplasia 2018 lecture 11. Dr H Awad FRCPath

Getting to the root of Cancer

FILE # WHAT PERCENTAGE OF PANCREATIC TUMORS ARE BENIGN

Section D: The Molecular Biology of Cancer

Oncolytic Virotherapy: Targeting Cancer Stem Cells

Tumorsphere Culture of Cancer Stem Cells (CSC) with the Cancer Stem Cell Medium, Application Note

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern

CANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)

Determination Differentiation. determinated precursor specialized cell

- is a common disease - 1 person in 3 can expect to contract cancer at some stage in their life -1 person in 5 can expect to die from it

Cancer Stem Cells, Therapeutic Implications

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007

Lecture 8 Neoplasia II. Dr. Nabila Hamdi MD, PhD

Leukemia Research Foundation Scientific Research Grant Recipients

Cancer stem cells old concepts, new insights

Contents. Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX

Cancer and Oncogenes Bioscience in the 21 st Century. Linda Lowe-Krentz

Differential Connexin Function Enhances Self-Renewal in Glioblastoma

Stem Cells. Induced Stem Cells

1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles:

September 20, Submitted electronically to: Cc: To Whom It May Concern:

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Mohammed El-Khateeb. Tumor Genetics. MGL-12 July 21 st 2013 台大農藝系遺傳學 Chapter 22 slide 1

Metastasis progression

Transformation of Normal HMECs (Human Mammary Epithelial Cells) into Metastatic Breast Cancer Cells: Introduction - The Broad Picture:

GENReports: Market & Tech Analysis

BIO 302: MARCH 4 & 6, 2014

Cancer Stem Cells & Glioblastoma

Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression

CHAPTER 6 SUMMARIZING DISCUSSION

Cancer and sornat ic evolution

Crosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea

Overview of mathematical biological models and their application in CML research

Neoplasia 18 lecture 6. Dr Heyam Awad MD, FRCPath

ANAT3231: lectures overview

LESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2

Carcinogenesis. Carcinogenesis. 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples

Potentially preventable cancers among Alaska Native people

Opposing effects of low versus high concentrations of vitamins/dietary ingredients Vitamin C and niacin on colon cancer stem cells (CSCs)

REVIEWS. Stem cell fate in cancer growth, progression and therapy resistance

Introduction to Cancer Biology

Stem cells in homeostasis and cancer of the gut

Cancer Fundamentals. Julie Randolph-Habecker, Ph.D. Director, Experimental Histopathology Shared Resource

Cancer stem cells: the lessons from precancerous stem cells

Karyotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl

CRIPTO-1 A POSSIBLE NEW BIOMARKER IN GLIOBLASTOMA MULTIFORME PIA OLESEN, MD, PHD STUDENT

Stacey J. Butler. A Thesis presented to The University of Guelph

CELL CYCLE REGULATION AND CANCER. Cellular Reproduction II

Cancer and Oncogenes Bioscience in the 21 st Century. Linda Lowe-Krentz October 11, 2013

The mutations that drive cancer. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge

From crypt stem cell to colorectal cancer

About OMICS Group Conferences

NGS Gateway Lab Services

oncogenes-and- tumour-suppressor-genes)

CANCER = Malignant Tumor = Malignant Neoplasm

Roles of microrna-mediated Drug Resistance in Tumor Stem Cells of Small Cell Lung Carcinoma

Triple Negative Breast Cancer

Aberrant cell Growth. Younas Masih New Life College of Nursing Karachi. 3/4/2016 Younas Masih ( NLCON)

Summary and Concluding Remarks

Mohammed El-Khateeb. Tumor Genetics. MGL-12 May 13 th Chapter 22 slide 1 台大農藝系遺傳學

Oncogenes and Tumor Suppressors MCB 5068 November 12, 2013 Jason Weber

OMP-305B83: A Novel, Potent DLL4 & VEGF Targeting Bispecific Antibody for the Treatment Of Solid Tumors

Is aspirin ready for colorectal cancer chemoprevention and adjuvant therapy?

Therapeutic implications of cancer stem cells. Cédric Blanpain, MD, PhD Laboratory of stem cells and cancer WELBIO, Université Libre de Bruxelles

Hypothesis of Cancer Stem Cells and Stem Cells of Head and Neck Cancer Biomarkers for their Identification

Stem cells are undifferentiated cells which are maintained within a specific niche. A stem cell

Oncology 101. Cancer Basics

Multistep Carcinogenesis

Tumour Structure and Nomenclature. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge

Overview of the core ideas in cancer research

icamp: Cancer biology tutorial II: recent developments in tumor biology, experimental methodology, and reference identification

Developing Better Medicine

ANAT3231: lectures overview

2008 Oncology Pharmacy Preparatory Review Course Learning Objectives

Lesson 19 Study Guide: Medical Biotechnology Cancer Treatment

Molecular Markers. Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC

mirna Dr. S Hosseini-Asl

Phoenix Molecular Designs

Transcription:

GENReports: Market & Tech Analysis Characteristics of Cancer Stem Cells (CSCs) > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director Select Biosciences, Inc. enal@selectbio.us!

Topic,IntroducEon,and,Scope! The,focus,of,this,GEN,Market,&,Tech,Analysis,Report,is,to,frame,the, challenging,space,of,cancer,stem,cells,(cscs), CSC,research,and,clinical,translaEon,has,been,hampered,by,the,lack,of, bona% fide% characterisecs, of, this, cellular, class, and, agreement, within, the,research,community,as,to,their,role,in,metastaec,development, Indeed,!many!have!ques?oned!the!existence!of!CSCs!in#vivo# Do! CSCs! originate! from! the! primary! tumor! and! then! traffic! within! the! circula?on!to!distal!sites!to!give!rise!to!metastases?! What! is! the! rela?onship! between! circula?ng! tumor! cells! (CTCs)! which! are! known!to!be!increased!in!number!in!the!circula?on!of!cancer!pa?ents!visoào vis!cscs?!!!!is!one!cellular!class!the!progenitor?! The,challenge,in,the,study,of,CSCs,is,compounded,by,the,fact,that,the, surface,phenotype,of,bona%fide%cscs,is,controversial, In,this,GEN,report,,we,have,sought,to,address,some,of,the,data,that,is, available,and,provide,a,view,of,this,marketplace,based,upon,primary, market,research,we,have,performed,on,researchers,studying,cscs,

SchemaEc,RepresentaEon,of,PotenEal,Origins,of, Precursor,Invasive,Cancer,Cells! Source:!!Industry!sources.!

Biology,of,CSCs, " The cancer stem cell (CSC) hypothesis states that cells with long life spans must exist within the bulk population of a cancer to sustain the multiple rounds of mutations necessary for cancer formation " According to this model, human cancers originate from tissue stem or progenitor cells, and only a small fraction of these cells (CSCs) have the capacity to proliferate indefinitely " First described in patients with acute myeloid leukemia (AML), CSCs share many of the hallmarks of normal stem cells. For example, both of these cell types have the capacity to self renew and differentiate, however, unlike the highly-regulated self-renewal and differentiation decisions of normal stem cells, it has been suggested that cancer cells undergo uncontrolled self-renewal and abnormal differentiation " Furthermore, CSCs metastasize to distant organs and tissues much like somatic stem cells migrate to distant tissues, and most importantly both cell types exhibit resistance to apoptotic stimuli CSCs Behave like Stem Cells, Exhibit Migratory Behavior, and " Any disturbance of the tightly regulated processes that control self-renewal, cell fate (proliferation vs. apoptosis) and differentiation of tissue stem or progenitor cells may favor the emergence Exhibit of CSCs and Resistance the subsequent to development Apoptosis. of cancer CSCs are Heterogeneous with Respect to Surface " While the precise identity of CSCs in a given type of cancer remains to be identified and is highly controversial at present, it appears that CSCs may arise either from the Marker Properties malignant transformation of a tissue stem or progenitor cell, or alternatively, from the abnormal re-activation of stem cell pathways in a committed progenitor cell " The seemingly distinct (from the bulk tumor) and relatively small population of CSCs possess unlimited self-renewal and proliferation capacity and ultimately potentially sustain tumor growth. However, the proportion of CSCs within the bulk population remains questionable and controversial

DescripEon,of,Selected,Markers,for,CSCs,, Marker, Aldehyde! dehydrogenase! Bmi1! CD24! CD44! CD90!(Thy1)! CD105! CD117!(cOkit)! CD133! CD166! EpCAM!(ESA)! Side!Popula?on! DefiniEon, ALDH!gene!superfamily!encodes!detoxifying!enzymes! Normally!measured!by!FACS!aWer!ALDEFLUOR!staining!of!live!cells! Polycomb!protein!that!suppresses!the!INK4A!and!ARF!genes! A!sialoglycoprotein!which!acts!as!a!ligand!for!POselec?n!enabling!cells!to!bind!platelets! Transmembrane!glycoprotein!that!binds!hyaluronan!(HA).! A!glycosylphospha?dylinositolOanchored!protein!(GPIOAP)! A!type!I!integral!membrane!protein! A!receptor!tyrosine!kinase!receptor!for!Stem!Cell!Factor!(SCF)! An!important!marker!for!several!classes!of!CSCs,!probably!not!a!universal!marker!for!CSCs! Ac?vated!leukocyteOcell!adhesion!molecule!(ALCAM)! Epithelial!cell!adhesion!molecule,!a!glycosylated!type!I!integral!membrane!protein.!!Involved! with!components!of!wnt!signaling!in!s?mula?ng!cell!prolifera?on!awer!cleavage!of!epcam! intracellular!domain! Side!popula?on!defines!cells!able!to!efflux!fluorescent!dyes,!appearing!fluorescent!dull!by! FACS.!!This!phenotype!is!usually!dependent!upon!the!ABC!superfamily!of!membrane! transporters!

Overview,of,Surface,Phenotypic,Markers,Associated,with,CSCN containing,populaeons,in,various,cancer,subntypes, Cancer Class Glioblastoma, medulloblastoma CD133 + Markers used for identification and/or purification of CSC population Colon carcinoma CD133 +, CD44 +, Lin, EpCAM(ESA) + Mammary carcinoma CD24 /low, CD44 + Lung cancer CD133 + Pancreas carcinoma CD44 +, CD24 +, EpCAM(ESA) +, CD133 + Hepatocellular cancer CD133 + Head and neck squamous cell carcinoma CD44 + Prostate carcinoma CD44 +, α 2 β 1 high, CD133 + Hematological malignancies CD34 +, CD38 " CSCs,with,Different,Surface,Phenotypes,[Surface,Marker,Expression],are,Found,in,Different, Types,of,Cancers., " There,is,SEll,Significant,Disagreement,as,to,whether,there,is,a, Universal,CSC,Phenotype.,

Some,Cancer,SubNTypes,and,Associated,CSC, CharacterisEcs, Cancer Sub-type CSC Characteristics Glioblastoma [Aggressive brain tumor] " Glioblastoma stem cells are enriched in a population of cells that express CD133 " Expression of this marker has been linked to poor clinical outcome for the patient " CD133 + cells reside in the perivascular niche in close contact with endothelial cells and this may drive the tumor vasculature Chronic Myeloid Leukemia [CML] " CML stem cells are implicated in disease persistence " Primitive CD34 + CD38 - CML cells have increased expression of the Bcr-Abl protein which is linked with genomic instability and resistance to kinase inhibitors Intestinal Cancer " Cells within the crypts of the stomach, small intestine, and colon that express the GPCR LGR5 are long-lived stem cells " When the tumor suppressor protein APC is lost, these cells give rise to microadenomas and adenomas Breast Cancer " Cells with CSC-like characteristics (ALDH + CD44 high CD24 low ) have been shown to be enriched in patients with breast cancer treated with chemotherapy Prostate Cancer " A subset of cells that are CD133 +, α 2 β 1+, and CD44 + with basal cell characteristics have been shown to be tumorigenic in the prostate CSCs with Different Surface Phenotypes [Surface Marker Expression] and Characteristics are Found in Various Types of Cancers

Colorectal,Cancer,Stem,Cells, " Colorectal,cancer,(CRC),is,one,of,the,most,commonly,diagnosed,and,lethal,cancers,worldwide, " CRC, is, a, leading, cause, of, morbidity, and, mortality, worldwide, with, >1.2, million, new, cancer, cases, and, 600,000,deaths,esEmated,in,2008, " CRC, results, from, a, series, of, geneec/epigeneec, alteraeons, and, interaceons, with, micronenvironmental, and,germnline,factors,,that,transform,normal,colonic,mucosa,into,an,aberrant,phenotype, " The, intesene, is, subject, to, a, complex, crosstalk, of, conserved, pathways, such, as, Wnt,, Notch,, and, Hedgehog,,which,control,the,balance,between,proliferaEon,,differenEaEon,,migraEon,,and,renewal, " The, Wnt, pathway,is, responsible, for, endoderm, formaeon, and, exerts, a, fundamental, role, in, crypt, development,,maintenance,and,proliferaeon cnmyc,,cyclin,d1,and,lgrn5,are,its,various,targets, " MutaEons,in,the,APC,gene,(80%,in,sporadic,cancers),,βNcatenin,,or,the,regulatory,proteins,in,the,Wnt, pathway, result, in, consetueve, acevaeon.,, This, may, lead, to, uncontrolled, proliferaeon,, a, shif, from, asymmetrical,to,symmetric,divisions,,and,augmented,cell,survival, " Wnt,signaling,is,also,involved,in,the,process,of,EMT, " Notch,may,drive,tumorigenesis,because,it,potenEates,proliferaEon,,and,inhibits,differenEaEon, " TGFNβ,is,an,inhibitor,of,intesEnal,epithelial,cell,proliferaEon,and,an,inducer,of,apoptosis, " The,Hedgehog,proteins,carry,signals,between,stromal,and,epithelial,cells, " In, colorectal, carcinogenesis,, acevaeon, of, the, phosphoinosiede, 3Nkinase, (PI3K), pathway, results, in, a, rapid,and,excessive,proliferaeon,of,intesenal,stem,cells, " CD133, expression, in, CRC, lines, correlates, with, stem, cell, poteneal,, worse, clinical, prognosis,, and, low, survival, " In, addieon, to, CD133,, other, markers, proposed, as, CSC, markers, include, CD44,, CD24,, CD166,, LgrN5,, and, ALDHN1,

Markers,Currently,UElized,to,Characterize,CSCs:, QuanEtaEve,Market,Penetrance, Percent!of!Respondents!Surveyed! 25%! 20%! 15%! 10%! 5%! Respondents!could!choose! 1!marker,!therefore!sum!of!! percentages!=!100%! 0%! " The!Most!Penetrant!Markers!in!the!Research!Community!are!EpCAM!and!CD133! " CD44!is!also!Penetrant!in!the!Research!Community!

SegmentaEon,of,the,CSC,Marketplace,visNàNvis, the,intracellular/signaling,pathway,studied! Percent!of!Respondents!Surveyed! 45%! 40%! 35%! 30%! 25%! 20%! 15%! 10%! 5%! 0%! Respondents!could!choose!1!pathway! which!they!study!primarily,!therefore!sum!of!! percentages!=!100%! EMT:,The,Most,Penetrant,Pathway,which,is,Being,Studied,in,CSCs,Space,

The,Cancer,Stem,Cells,(CSCs),is,currently,an,amorphous, field,wherein,the,cscs,are,not,well,characterized,and, indeed,there,is,much,controversy,in,the,field,as,to,their, surface,phenotype,,intracellular,pathways,,and,role,in, metastaec,progression, We,have,sought,to,understand,the,marketplace,by, performing,market,surveys,of,researchers,studying, CSCs,,thereby,illuminaEng,the,current,research,trends, Much,remains,to,be,studied,in,this,field,as,the, interrelaeonship,between,cscs,and,ctcs,needs,to,be, clarified, CSCs,may,be,therapeuEc,targets,as,well,as,potenEally, biomarkers,for,cancer,progression,monitoring, In Summary